A House committee says it will investigate whether the Food and Drug Administration fully disclosed the disagreement among its scientists about whether antidepressants might be linked to suicide in children.
The FDA insists it is not clear whether the drugs have any link to suicidal behavior by children or teenagers, noting that depression itself can lead to suicide. An extensive agency investigation is under way; results are due this summer.
Dr. John Grohol is the CEO and founder of Psych Central. He is an author, researcher and expert in mental health online, and has been writing about online behavior, mental health and psychology issues -- as well as the intersection of technology and human behavior -- since 1992. Dr. Grohol sits on the editorial board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory Medicine.Like this author?
Catch up on other posts by John M. Grohol, PsyD (or subscribe to their feed).
Comments
This post currently has no comments. You can read the comments or leave your own thoughts on our new comments page.
Trackbacks
Last reviewed: By John M. Grohol, Psy.D. on 19 Apr 2004
Published on PsychCentral.com. All rights reserved.
APA Reference
Grohol, J. (2004). House Panel To Probe FDA, Antidepressants. Psych Central. Retrieved on February 14, 2012, from http://psychcentral.com/blog/archives/2004/04/19/house-panel-to-probe-fda-antidepressants/
Grohol, J. (2004). House Panel To Probe FDA, Antidepressants. Psych Central. Retrieved on February 14, 2012, from http://psychcentral.com/blog/archives/2004/04/19/house-panel-to-probe-fda-antidepressants/
